Named on one round in the feed.
Since ~ 2026-10-16
ROUNDS
1
joined, none as lead
ROUNDS JOINED · USD
$1.5M
across 1 round
TOP SECTOR
Biotech
1 of 1 round
Named on one round in the feed.
Since ~ 2026-10-16
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
TangGene, Inc. TangGene specializes in developing innovative therapies for autoimmune diseases using a proprietary nanoparticle platform to stimulate immune responses. | NJIEF investment Developing, 2 sources | $1.5M | ~ 2026-10-16 | [ PART ] |
No one else named on these rounds.